Kezar Life Sciences

Yahoo Finance • 8 months ago

Highlights – June Quarter 2025

Novo completed its maiden RC drill program at the Clone prospect as part of the Tibooburra Gold Project in May 2025 testing 500 m of strike. Drilling produced significant high-grade gold intercepts including: 12 m @ 5.90 g/t Au from 16 m,... Full story

Yahoo Finance • 9 months ago

Kezar Life Sciences stock gains after FDA lifts partial clinical hold

Investing.com -- Kezar Life Sciences Inc (NASDAQ:KZR) stock gained 4% after the FDA lifted a partial clinical hold on its completed Phase 2a trial evaluating zetomipzomib in patients with autoimmune hepatitis (AIH). The clinical-stage b... Full story

Yahoo Finance • 3 years ago

Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., June 09, 2023--(BUSINESS WIRE)--Kezar Life Sciences, Inc., (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, t... Full story

Yahoo Finance • 3 years ago

Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update

PALIZADE Phase 2b clinical trial evaluating zetomipzomib in lupus nephritis to initiate in first half of 2023 KZR-261 dose escalation study currently enrolling sixth cohort; the dose expansion study expected to initiate in second half of 2... Full story

Yahoo Finance • 4 years ago

Kezar Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update

Announced positive topline results from the MISSION Phase 2 Trial evaluating zetomipzomib for the treatment of patients with lupus nephritis Appointed Nick Mordwinkin, Pharm.D., Ph.D. as Chief Business Officer Cash, cash equivalents and ma... Full story

Yahoo Finance • 4 years ago

Healthcare Breakthroughs: KZR, NMLSF, AGRX, LMLLF Report Latest Advances in Novel Therapeutics for Inflammatory Diseases, Oncology, and Autism

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: Kezar Life Sciences (NASDAQ: KZR), Nova Mentis Life... Full story

Yahoo Finance • 4 years ago

VOX PROVIDES DEVELOPMENT & EXPLORATION UPDATES

TORONTO, April 5, 2022 /CNW/ - Vox Royalty Corp. (TSXV: VOX) (OTCQX: VOXCF) ("Vox" or the "Company"), a high growth precious metals focused royalty company, is pleased to provide recent development and exploration updates from royalty oper... Full story